These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7447363)

  • 1. Further observations on vesicourethral dopamine receptors--a urodynamic study with haloperidol.
    Vaidyanathan S; Rao MS; Bapna BC; Sharma PL; Chary KS; Swamy RP
    Ann Clin Res; 1980 Apr; 12(2):49-51. PubMed ID: 7447363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of dopamine receptors in vesicourethral function. A urodynamic study with dopamine receptor antagonist metoclopramide.
    Vaidyanathan S; Rao MS; Bapna BC; Chary KS; Swamy RP
    Ann Clin Res; 1980 Feb; 12(1):1-4. PubMed ID: 7377750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postoperative vesicourethral neurogenic dysfunction: the conceptual and clinical aspects based on the analysis of a series of 152 patients].
    Esteban Fuertes M; Salinas Casado J; Resel Estévez L; Sánchez Chapado M
    Arch Esp Urol; 1998 Nov; 51(9):901-16. PubMed ID: 9887564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations.
    Sakakibara R; Uchiyama T; Arai K; Yamanishi T; Hattori T
    J Neurol Sci; 2004 Mar; 218(1-2):67-72. PubMed ID: 14759635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives.
    Barbalias GA; Nikiforidis G; Liatsikos EN
    J Urol; 1998 Jul; 160(1):106-11. PubMed ID: 9628615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
    JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
    Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E
    Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenic bladder: urodynamic and surgical aspects.
    Kataria R; Bajpai M; Lall A; Gupta DK; Grover VP; Mitra DK
    Indian J Pediatr; 1997; 64(6 Suppl):68-76. PubMed ID: 11129884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of bladder dysfunction to lesion site in multiple sclerosis.
    Araki I; Matsui M; Ozawa K; Takeda M; Kuno S
    J Urol; 2003 Apr; 169(4):1384-7. PubMed ID: 12629367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic responses to anal stretch in patients with detrusor sphincter dyssynergia.
    Huang YH; Chen SL; Tsai SJ; Bih LI; Lew HL
    Arch Phys Med Rehabil; 2008 Sep; 89(9):1748-52. PubMed ID: 18760159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sphincter EMG in urodynamic studies in neurogenic miction disorders].
    Grisar P; Vereecken RL
    Acta Belg Med Phys; 1985 Oct; 8 Spec No():32-41. PubMed ID: 2934924
    [No Abstract]   [Full Text] [Related]  

  • 12. Striated urethral sphincter activity does not alter urethral pressure during filling cystometry.
    Kenton K; Fitzgerald MP; Brubaker L
    Am J Obstet Gynecol; 2005 Jan; 192(1):55-9. PubMed ID: 15672003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
    Kuo HC
    J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility].
    Mazo EB; Krivoborodov GG; Efremov NS
    Ter Arkh; 2008; 80(10):49-52. PubMed ID: 19105415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
    Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
    J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder dysfunction in patients with cauda equina lesions.
    Podnar S; Trsinar B; Vodusek DB
    Neurourol Urodyn; 2006; 25(1):23-31. PubMed ID: 16224798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of thyrotropin-releasing hormone to neurogenic bladder caused by olivo-ponto-cerebellar atrophy].
    Murayama K; Katsumi T
    Hinyokika Kiyo; 1985 Mar; 31(3):495-8. PubMed ID: 3927664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overactive bladder inhibition in response to pelvic floor muscle exercises.
    Shafik A; Shafik IA
    World J Urol; 2003 May; 20(6):374-7. PubMed ID: 12682771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Video urodynamic findings in men with the central cord syndrome.
    Smith CP; Kraus SR; Nickell KG; Boone TB
    J Urol; 2000 Dec; 164(6):2014-7. PubMed ID: 11061905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urethral sphincter EMG as event detector for Neurogenic detrusor overactivity.
    Hansen J; Borau A; Rodríguez A; Vidal J; Sinkjaer T; Rijkhoff NJ
    IEEE Trans Biomed Eng; 2007 Jul; 54(7):1212-9. PubMed ID: 17605352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.